In results presented at the American Association for Cancer Research (AACR) Annual Meeting 2015, a University of Colorado Cancer Center study shows that orally administering the chemical silibinin, purified from milk thistle, slows the ability of colorectal cancer stem cells to grow the disease.
When stem cells from tumors grown in silibinin-fed conditions were reinjected into new models, the cells failed to develop equally aggressive tumors even in the absence of silibinin.
